Aummune develops a first-of-its-kind individual drug-customization platform that utilizes a unique efficacy-driven selection process to match and produce a patient-specific tri-functional aptamer drug that safely and synergistically induces cancer cell death and activates both innate and adaptive immune responses
| Website | http://www.aummune.com |
| Employees | 6 (6 on RocketReach) |
| Founded | 2017 |
| Industry | Biotechnology Research, Business Services General, Therapeutics, Other Pharmaceuticals and Biotechnology, Business Services, Health Care |
| Keywords | Cancer Treatment, Therapeutics, Personalized Medicine, Aptamer Therapeutics, Immunotherapy, Targeted Therapy, Cancer Research, Oncology, Biotechnology, Pharmaceutical, Drug Development, Precision Medicine, Genetic Testing, Clinical Trials, Healthcare, Medical Technology, Biopharma |
| Competitors | Johnson & Johnson, Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Regeneron, Moderna Therapeutics, Novavax, CureVac +35 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies |
Looking for a particular Aummune employee's phone or email?
Revital Cohen is the Director Of Quality Assurance of Aummune.
6 people are employed at Aummune.
Aummune is based in Tel Aviv, Tel Aviv.
The NAICS codes for Aummune are [5417, 54, 541713, 541, 54171].
The SIC codes for Aummune are [87, 873].